IBD - GI Flashcards
metoclopramide MOA
dopamine antagonists enhances upper GI tract response to ACH to enhance motility - increases colon motility - shortens transit time
metoclopramide uses
gastroparesis, persistent GERD, N/V - can be useful for diabetes - short term use only given risk of TD <12wks
metoclopramide side effects
drowsiness, dystonia, HA
metoclopramide caution with
BLACK BOX WARNING: can cause tardative dyskinesia (irreversible)
Cl: GI hemorrhage, mechanical obstruction, perforation
domperidone MOA
peripheral dopamine antagonists increases esophageal peristalsis, gastric motility and gastric emptying decreases small bowel transit time
domperidone uses
gastroparesis/motility disorder, N/V
domperidone side effects
HA, migraines, xerostomia
domperidone caution with
BLACK BOX WARNING: increased risk of cardiac arrhythmias or sudden cardiac death
caution with other QT prolonging agents
Cl for patients with prolactinomas
erythromycin MOA
macrolide antibiotics - motilin agonists - increases gastric contractions
erythromycin uses
gastroparesis - use for max 4 wks duration d/t tachyphylaxis
erythromycin side effects
cardiovascular arrhythmias, QT prolongation, superinfection (c diff)
erythromycin caution with
major inhibitor of CYP3A4
myasthenia gravis - may exacerbate or cause symptoms
neostigmine MOA
acetylcholinesterase inhibitor
neostigmine use
acute colonic pseudo - obstruction - myasthenia gravis - post op bladder distention/urinary frequency
neostigmine side effects
cardiac arrhythmias - especially bradycardia
dizziness, drowsiness, diarrhea
neostigmine caution
cardiovascular disease